Page last updated: 2024-11-06

mitomycin and Diabetes Mellitus, Type 1

mitomycin has been researched along with Diabetes Mellitus, Type 1 in 4 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research Excerpts

ExcerptRelevanceReference
"Hypoglycemia is associated with cognitive dysfunction, but the exact mechanisms have not been elucidated."1.91Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage. ( Chen, Z; Huang, C; Huang, L; Ke, S; Lin, L; Liu, L; Wang, L; Wu, Y, 2023)
"Mitomycin C treatment of MNC from IDDM patients abolished insulin secretion inhibition in recipient mice."1.29Insulin secretion by pancreas of athymic mice injected with peripheral mononuclear cells from insulin-dependent diabetic patients. ( Arata, M; Basabe, JC; Fabiano de Bruno, L; Gagliardi, G; Goncalvez Volpini, W; Quintans, CJ, 1995)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Lin, L1
Chen, Z1
Huang, C1
Wu, Y1
Huang, L1
Wang, L1
Ke, S1
Liu, L1
Babiker, S1
Elsayed, ME1
Dhaygude, A1
Madgula, I1
Arata, M1
Fabiano de Bruno, L1
Goncalvez Volpini, W1
Gagliardi, G1
Quintans, CJ1
Basabe, JC1
Dispenzieri, A1
Loprinzi, CL1

Other Studies

4 other studies available for mitomycin and Diabetes Mellitus, Type 1

ArticleYear
Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage.
    Molecular neurobiology, 2023, Volume: 60, Issue:2

    Topics: Animals; Antioxidants; Blood-Brain Barrier; Cognitive Dysfunction; Diabetes Mellitus, Type 1; Glucos

2023
A complex case of haemodialysis induced increased intraocular pressure.
    European journal of ophthalmology, 2019, Volume: 29, Issue:1_suppl

    Topics: Acetazolamide; Antihypertensive Agents; Diabetes Mellitus, Type 1; Glaucoma, Neovascular; Humans; In

2019
Insulin secretion by pancreas of athymic mice injected with peripheral mononuclear cells from insulin-dependent diabetic patients.
    Metabolism: clinical and experimental, 1995, Volume: 44, Issue:11

    Topics: Adolescent; Animals; Antibiotics, Antineoplastic; Cell Transplantation; Cells, Cultured; Child; Chil

1995
Chemotherapy-induced insulin-dependent diabetes mellitus.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:3

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Dexamethasone;

1997